9781773637310 - Psychedelic Capitalism de Brownlee, Jamie; Walby, Kevin (25 résultats)

Etat : As New. Unread book in perfect condition.

Etat : New.

Paperback. Etat : new. Paperback. Psychedelics have long been sanctioned as dangerous substances. Today, psychedelics are enjoying a new found appeal, even being idealized as wonder drugs. As part of the so-called psychedelic renaissance, reports abound about the benefits of these substances for remedying individual mental health issues and bringing about social change. Offering a critical view of these developments, Psychedelic Capitalism locates this renaissance in the context of corporate capture, medicalization, and the war on drugs. Wealthy entrepreneurs are investing billions in the psychedelics industry. Biotechnology firms are racing to capture intellectual property and monopolize psychedelic supply chains. Venture capitalists are leveraging the prospects of a lucrative mass market. Together, these actors are appropriating Indigenous knowledge and claiming ownership over substances that have been in the public domain for centuries. Brownlee and Walby ask if corporations and the medical establishment are suited to steward the mainstreaming of psychedelics, raising concerns with how the psychedelic renaissance is entrenching systems of inequality, limiting access and affordability, and increasing the reach of drug war surveillance and criminalization. Interrogating the consequences of psychedelic capitalism, the authors point to what could be gained from a just and equitable psychedelic future rooted in the public interest. Interrogating the consequences of psychedelic capitalism, Brownlee and Walby point to what could be gained from a just and equitable psychedelic future rooted in the public interest. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Paperback. Etat : New. Psychedelics have long been sanctioned as dangerous substances. Today, psychedelics are enjoying a new found appeal, even being idealized as wonder drugs. As part of the so-called psychedelic renaissance, reports abound about the benefits of these substances for remedying individual mental health issues and bringing about social change. Offering a critical view of these developments, Psychedelic Capitalism locates this renaissance in the context of corporate capture, medicalization, and the war on drugs. Wealthy entrepreneurs are investing billions in the psychedelics industry. Biotechnology firms are racing to capture intellectual property and monopolize psychedelic supply chains. Venture capitalists are leveraging the prospects of a lucrative mass market. Together, these actors are appropriating Indigenous knowledge and claiming ownership over substances that have been in the public domain for centuries. Brownlee and Walby ask if corporations and the medical establishment are suited to steward the mainstreaming of psychedelics, raising concerns with how the psychedelic renaissance is entrenching systems of inequality, limiting access and affordability, and increasing the reach of drug war surveillance and criminalization. Interrogating the consequences of psychedelic capitalism, the authors point to what could be gained from a just and equitable psychedelic future rooted in the public interest.

Paperback. Etat : New. Psychedelics have long been sanctioned as dangerous substances. Today, psychedelics are enjoying a new found appeal, even being idealized as wonder drugs. As part of the so-called psychedelic renaissance, reports abound about the benefits of these substances for remedying individual mental health issues and bringing about social change. Offering a critical view of these developments, Psychedelic Capitalism locates this renaissance in the context of corporate capture, medicalization, and the war on drugs. Wealthy entrepreneurs are investing billions in the psychedelics industry. Biotechnology firms are racing to capture intellectual property and monopolize psychedelic supply chains. Venture capitalists are leveraging the prospects of a lucrative mass market. Together, these actors are appropriating Indigenous knowledge and claiming ownership over substances that have been in the public domain for centuries. Brownlee and Walby ask if corporations and the medical establishment are suited to steward the mainstreaming of psychedelics, raising concerns with how the psychedelic renaissance is entrenching systems of inequality, limiting access and affordability, and increasing the reach of drug war surveillance and criminalization. Interrogating the consequences of psychedelic capitalism, the authors point to what could be gained from a just and equitable psychedelic future rooted in the public interest.

PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000.

Etat : New.

Paperback or Softback. Etat : New. Psychedelic Capitalism. Book.

Paperback. Etat : Brand New. 256 pages. 9.00x6.00x0.25 inches. In Stock.

paperback. Etat : New.

Etat : New. 2025. paperback. . . . . .

Etat : New. In.

Etat : New.

Paperback / softback. Etat : New. New copy - Usually dispatched within 4 working days.

Etat : As New. Unread book in perfect condition.

Etat : New. 2025. paperback. . . . . . Books ship from the US and Ireland.

paperback. Etat : New. Special order direct from the distributor.

Paperback. Etat : Brand New. 256 pages. 9.00x6.00x0.25 inches. In Stock.

Etat : NEW.

Paperback. Etat : new. Paperback. Psychedelics have long been sanctioned as dangerous substances. Today, psychedelics are enjoying a new found appeal, even being idealized as wonder drugs. As part of the so-called psychedelic renaissance, reports abound about the benefits of these substances for remedying individual mental health issues and bringing about social change. Offering a critical view of these developments, Psychedelic Capitalism locates this renaissance in the context of corporate capture, medicalization, and the war on drugs. Wealthy entrepreneurs are investing billions in the psychedelics industry. Biotechnology firms are racing to capture intellectual property and monopolize psychedelic supply chains. Venture capitalists are leveraging the prospects of a lucrative mass market. Together, these actors are appropriating Indigenous knowledge and claiming ownership over substances that have been in the public domain for centuries. Brownlee and Walby ask if corporations and the medical establishment are suited to steward the mainstreaming of psychedelics, raising concerns with how the psychedelic renaissance is entrenching systems of inequality, limiting access and affordability, and increasing the reach of drug war surveillance and criminalization. Interrogating the consequences of psychedelic capitalism, the authors point to what could be gained from a just and equitable psychedelic future rooted in the public interest. Interrogating the consequences of psychedelic capitalism, Brownlee and Walby point to what could be gained from a just and equitable psychedelic future rooted in the public interest. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Paperback. Etat : new. Paperback. Psychedelics have long been sanctioned as dangerous substances. Today, psychedelics are enjoying a new found appeal, even being idealized as wonder drugs. As part of the so-called psychedelic renaissance, reports abound about the benefits of these substances for remedying individual mental health issues and bringing about social change. Offering a critical view of these developments, Psychedelic Capitalism locates this renaissance in the context of corporate capture, medicalization, and the war on drugs. Wealthy entrepreneurs are investing billions in the psychedelics industry. Biotechnology firms are racing to capture intellectual property and monopolize psychedelic supply chains. Venture capitalists are leveraging the prospects of a lucrative mass market. Together, these actors are appropriating Indigenous knowledge and claiming ownership over substances that have been in the public domain for centuries. Brownlee and Walby ask if corporations and the medical establishment are suited to steward the mainstreaming of psychedelics, raising concerns with how the psychedelic renaissance is entrenching systems of inequality, limiting access and affordability, and increasing the reach of drug war surveillance and criminalization. Interrogating the consequences of psychedelic capitalism, the authors point to what could be gained from a just and equitable psychedelic future rooted in the public interest. Interrogating the consequences of psychedelic capitalism, Brownlee and Walby point to what could be gained from a just and equitable psychedelic future rooted in the public interest. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Paperback. Etat : New. Psychedelics have long been sanctioned as dangerous substances. Today, psychedelics are enjoying a new found appeal, even being idealized as wonder drugs. As part of the so-called psychedelic renaissance, reports abound about the benefits of these substances for remedying individual mental health issues and bringing about social change. Offering a critical view of these developments, Psychedelic Capitalism locates this renaissance in the context of corporate capture, medicalization, and the war on drugs. Wealthy entrepreneurs are investing billions in the psychedelics industry. Biotechnology firms are racing to capture intellectual property and monopolize psychedelic supply chains. Venture capitalists are leveraging the prospects of a lucrative mass market. Together, these actors are appropriating Indigenous knowledge and claiming ownership over substances that have been in the public domain for centuries. Brownlee and Walby ask if corporations and the medical establishment are suited to steward the mainstreaming of psychedelics, raising concerns with how the psychedelic renaissance is entrenching systems of inequality, limiting access and affordability, and increasing the reach of drug war surveillance and criminalization. Interrogating the consequences of psychedelic capitalism, the authors point to what could be gained from a just and equitable psychedelic future rooted in the public interest.

Paperback. Etat : New. New Book, Direct from Publisher.

Taschenbuch. Etat : Neu. Neuware - Psychedelics have long been sanctioned as dangerous substances. Today, psychedelics are enjoying a new found appeal, even being idealized as wonder drugs. As part of the so-called psychedelic renaissance, reports abound about the benefits of these substances for remedying individual mental health issues and bringing about social change. Offering a critical view of these developments, Psychedelic Capitalism locates this renaissance in the context of corporate capture, medicalization, and the war on drugs. Wealthy entrepreneurs are investing billions in the psychedelics industry. Biotechnology firms are racing to capture intellectual property and monopolize psychedelic supply chains. Venture capitalists are leveraging the prospects of a lucrative mass market. Together, these actors are appropriating Indigenous knowledge and claiming ownership over substances that have been in the public domain for centuries. Brownlee and Walby ask if corporations and the medical establishment are suited to steward the mainstreaming of psychedelics, raising concerns with how the psychedelic renaissance is entrenching systems of inequality, limiting access and affordability, and increasing the reach of drug war surveillance and criminalization. Interrogating the consequences of psychedelic capitalism, the authors point to what could be gained from a just and equitable psychedelic future rooted in the public interest.

Paperback. Etat : New. Psychedelics have long been sanctioned as dangerous substances. Today, psychedelics are enjoying a new found appeal, even being idealized as wonder drugs. As part of the so-called psychedelic renaissance, reports abound about the benefits of these substances for remedying individual mental health issues and bringing about social change. Offering a critical view of these developments, Psychedelic Capitalism locates this renaissance in the context of corporate capture, medicalization, and the war on drugs. Wealthy entrepreneurs are investing billions in the psychedelics industry. Biotechnology firms are racing to capture intellectual property and monopolize psychedelic supply chains. Venture capitalists are leveraging the prospects of a lucrative mass market. Together, these actors are appropriating Indigenous knowledge and claiming ownership over substances that have been in the public domain for centuries. Brownlee and Walby ask if corporations and the medical establishment are suited to steward the mainstreaming of psychedelics, raising concerns with how the psychedelic renaissance is entrenching systems of inequality, limiting access and affordability, and increasing the reach of drug war surveillance and criminalization. Interrogating the consequences of psychedelic capitalism, the authors point to what could be gained from a just and equitable psychedelic future rooted in the public interest.